An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...
Dual-positive cells are circulating cells that bear both tumor-cell and immune-cell markers, and are thought to be hybrid cells resulting from rare fusions of tumor cells with immune cells. Recent ...
Median transduced CD34+ cells: 80% Median DP cell dose: 6.9 x10 6 CD34+ cells Median DP VCN (copies per diploid genome): 3.3 The first patient treated with LentiGlobin (Group C) made using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results